This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of trunk, unspecified
CD2_BENIGN_CONNSOFT_TRUNK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi trunci
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of trunk, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Connective and other soft tissue of trunk, unspecified
- Other benign neoplasms of connective and other soft tissue
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 220 | 130 | 90 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 44.81 | 41.04 | 50.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 197
- Matched controls
- 1970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.6
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of trunk, unspecified
+∞
176.7
142
*
21502
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Trunci
+∞
52.5
48
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
17.8
35.9
58
45
130
Kela drug reimbursment
Malignant tumour
+∞
16.9
16
*
H02AB02
ATC
dexamethasone; systemic
17.5
14.3
22
14
A04AA02
ATC
granisetron; systemic, transdermal
149.8
13.6
14
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.1
10.5
43
125
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
104.8
9.5
10
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
104.8
9.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.3
8.9
19
25
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
8.9
8.8
18
22
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
B01AB05
ATC
enoxaparin; parenteral
2.5
7.0
63
311
ZXA00
NOMESCO Finland
Right side
2.4
6.5
64
328
N02AA05
ATC
oxycodone; systemic
3.3
6.5
32
108
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
6.5
56
269
WF003
NOMESCO Finland
Adjuvant radiotherapy
72.1
6.5
7
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
72.1
6.5
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
33
72
5.22
14.79
4.5
1.7
22.3
2.4
ug/l
0.59
24
53
49
220
2.58
7.20
4.3
2.7
0.8
0.8
mmol/l
1.70
44
205
83
505
2.03
5.78
6.1
2.0
2.4
2.4
mmol/l
0.35
71
426
30
132
2.47
4.53
3.6
1.9
76.0
65.8
ml/min/173m2
0.91
12
52
61
359
1.97
4.51
3.1
1.8
—
—
—
0
0
38
188
2.23
4.42
4.9
4.6
1.0
1.0
mmol/l
0.19
32
168
116
844
1.79
4.35
8.4
3.7
9.5
12.0
umol/l
3.22
109
787
10
22
4.71
4.35
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
37
3.67
4.11
1.8
2.1
0.4
0.3
u/ml
—
5
19
19
73
2.75
3.75
11.3
5.6
25.7
24.8
mmol/l
0.47
19
73
20
81
2.62
3.58
15.8
6.5
24.4
24.9
mmol/l
0.33
20
73
137
1090
1.68
3.38
5.5
4.2
2.8
420.7
e6/l
—
6
17
51
310
1.84
3.35
1.7
1.7
1084.8
1159.9
nmol/l
0.22
41
241
96
701
1.66
3.28
8.7
4.4
1.2
1.2
mmol/l
1.84
85
623
103
773
1.63
3.11
10.8
4.9
1.2
1.2
mmol/l
2.46
86
671
154
1284
1.66
2.98
10.5
5.2
75.4
74.2
u/l
0.14
142
1178
42
249
1.85
2.97
1.6
1.7
—
—
—
0
0
32
173
1.99
2.96
1.6
1.7
—
—
—
0
0
45
274
1.81
2.92
3.0
2.4
2.2
3.4
e6/l
0.60
24
145
67
461
1.65
2.81
3.7
2.6
0.3
0.4
e6/l
0.64
51
340
120
951
1.58
2.79
14.5
6.4
4.2
4.2
e9/l
0.01
110
818
31
174
1.91
2.59
1.5
1.7
—
—
—
0
0
79
585
1.55
2.39
3.6
2.7
—
—
—
0
0
122
994
1.51
2.35
6.7
3.8
6.4
6.7
mmol/l
1.20
116
907
6
13
4.71
2.28
1.0
1.2
—
—
—
0
0
7
18
3.98
2.27
1.0
1.3
—
—
—
0
0
93
721
1.50
2.25
5.2
3.5
—
—
—
0
0
44
287
1.67
2.24
2.9
2.4
0.6
1.3
e6/l
1.86
25
159
47
312
1.64
2.24
4.9
2.1
2.4
2.4
mmol/l
0.68
42
261
29
169
1.82
2.17
11.9
5.8
5.5
5.3
kpa
0.39
29
159
29
169
1.82
2.17
11.8
5.8
14.2
12.0
kpa
1.19
29
161
28
166
1.79
1.99
12.2
5.9
0.7
1.6
mmol/l
0.62
21
133
55
392
1.54
1.94
1.9
1.7
0.7
1.1
mg/l
1.39
46
293
6
17
3.60
1.85
1.0
1.2
—
—
—
0
0
16
82
2.03
1.74
3.8
3.1
1.5
1.9
mmol/l
0.16
11
62
5
13
3.91
1.72
1.0
1.4
—
—
—
0
0
70
537
1.45
1.71
2.0
2.0
54.9
56.2
u/l
0.15
65
497
6
19
3.22
1.67
1.0
1.4
592.8
264.9
pmol/l
—
6
13
7
25
2.86
1.66
1.0
1.3
—
—
—
0
0
193
1788
1.65
1.64
20.2
11.3
25.2
21.7
mg/l
0.73
165
1358
7
26
2.75
1.59
2.3
1.4
—
—
—
0
0
8
33
2.48
1.55
1.5
1.2
—
—
—
0
0
8
33
2.48
1.55
1.5
1.2
—
—
—
0
0
5
15
3.38
1.53
1.2
1.3
—
—
—
0
0
35
239
1.55
1.49
2.9
2.2
13.1
14.0
umol/l
0.30
35
219
7
28
2.55
1.46
1.0
1.3
—
—
—
0
0
9
40
2.30
1.42
1.3
1.3
—
—
—
0
0
10
47
2.18
1.36
1.2
1.2
—
—
—
0
0
137
1211
1.35
1.33
3.3
2.9
55.0
41.4
u/l
0.65
126
1134
47
352
1.43
1.29
2.9
3.8
61.2
226.9
ng/l
0.95
28
262
8
38
2.15
1.19
1.1
1.1
—
—
—
0
0
154
1668
0.74
1.17
5.5
5.6
39.0
39.5
mmol/mol
0.28
138
1559
15
89
1.74
1.10
2.5
2.3
0.2
0.2
e6/l
0.04
15
84
165
1760
0.75
1.02
4.4
4.3
5.9
5.9
mmol/l
0.02
151
1614
15
95
1.62
0.90
1.4
1.5
—
—
—
0
0
8
44
1.85
0.87
1.3
1.1
—
—
—
0
0
127
1155
1.24
0.80
3.0
3.2
—
—
—
0
0
12
74
1.66
0.80
1.3
1.2
14.3
26.7
iu/l
1.34
12
63
82
712
1.24
0.79
2.8
2.2
76.5
75.7
nmol/l
0.10
73
628
0
28
0.00
0.76
0.0
1.1
—
2.1
—
0
12
159
1683
0.80
0.73
5.8
4.5
1.7
1.9
mu/l
1.45
148
1545
82
718
1.23
0.73
2.3
1.9
95.1
97.2
pmol/l
0.13
47
366
89
787
1.22
0.72
3.2
2.6
146.4
99.0
ug/l
0.82
83
734
141
1307
1.22
0.70
4.8
3.9
10.0
11.0
mm/h
0.44
135
1194
20
145
1.42
0.68
1.8
1.8
387.9
378.1
nmol/l
0.08
20
130
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
49
412
1.24
0.63
1.7
1.5
21.9
20.6
nmol/l
0.21
39
357
8
49
1.66
0.63
1.5
1.6
—
—
—
0
0
11
163
0.66
0.62
2.2
1.7
—
—
—
0
0
29
229
1.31
0.61
12.2
18.7
1.3
1.2
inr
—
8
33
10
150
0.65
0.60
5.8
2.8
—
—
—
0
0
174
1814
0.80
0.60
4.8
4.8
2.7
2.8
mmol/l
0.46
158
1692
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
14
98
1.46
0.58
1.4
1.3
—
—
—
0
0
94
854
1.18
0.54
4.1
3.5
0.0
0.0
estimate
0.00
14
134
6
97
0.61
0.53
1.0
1.2
—
—
—
0
0
9
63
1.45
0.53
1.6
1.6
—
—
—
0
0
9
65
1.40
0.51
1.7
1.2
—
—
—
0
0
177
1700
1.21
0.49
18.8
10.0
84.3
82.5
ml/min/173m2
0.45
138
1359
92
843
1.16
0.46
5.4
4.7
0.0
0.0
estimate
0.00
14
135
7
50
1.41
0.45
3.0
1.5
—
—
—
0
0
7
51
1.38
0.44
1.1
1.1
34.7
38.4
g/l
—
7
46
14
104
1.37
0.44
14.1
2.6
1.2
1.2
mmol/l
0.21
14
84
5
32
1.58
0.42
1.6
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
5
34
1.48
0.40
1.4
1.8
—
—
—
0
0
7
103
0.67
0.40
2.1
1.7
—
—
—
0
0
90
832
1.14
0.39
3.8
3.4
0.0
0.0
estimate
0.00
12
137
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
24
198
1.24
0.38
3.8
4.4
32.4
32.2
%
0.02
13
137
171
1650
1.16
0.38
23.0
12.4
39.1
40.4
%
1.16
136
1239
8
114
0.69
0.38
2.4
2.1
15.7
14.5
nmol/l
—
8
107
22
180
1.25
0.37
7.3
7.0
—
—
—
0
0
45
399
1.16
0.35
4.8
3.3
18.7
24.3
%
2.02
24
164
6
44
1.37
0.34
1.0
1.3
—
44.5
—
0
5
46
410
1.15
0.33
3.4
2.0
3.4
2.8
mg/l
0.57
41
345
173
1780
0.87
0.33
4.4
4.3
4.6
4.6
mmol/l
0.16
159
1670
69
641
1.11
0.27
3.8
3.4
48.8
98.4
ng/l
0.41
42
430
173
1768
0.90
0.22
4.4
4.2
1.5
1.5
mmol/l
0.17
158
1649
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
36
327
1.12
0.21
1.5
1.7
398.1
432.3
pmol/l
0.45
29
272
6
52
1.16
0.19
1.3
1.6
—
—
—
0
0
167
1705
0.91
0.19
3.9
3.9
1.3
1.3
mmol/l
0.44
150
1574
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
5
66
0.75
0.17
3.2
1.9
—
—
—
0
0
52
488
1.09
0.17
3.2
2.8
1131.3
1149.5
ng/l
0.02
45
398
44
471
0.92
0.16
1.8
1.7
1.4
1.4
mmol/l
0.06
38
405
26
286
0.90
0.16
3.3
2.5
0.8
0.7
ug/l
0.39
19
181
47
441
1.08
0.15
4.2
3.5
0.0
0.0
estimate
0.50
13
130
21
233
0.89
0.15
1.9
2.0
—
—
—
0
0
9
110
0.81
0.13
1.0
1.0
—
—
—
0
0
30
279
1.09
0.12
1.3
1.4
—
—
—
0
0
193
1909
1.09
0.11
23.2
12.8
76.5
76.2
umol/l
0.04
193
1909
141
1383
1.05
0.11
4.5
3.8
14.9
14.7
pmol/l
0.31
129
1256
19
208
0.91
0.11
2.0
1.9
—
—
—
0
0
14
125
1.13
0.10
1.4
1.3
152.5
132.2
iu/ml
—
5
51
11
99
1.12
0.06
1.5
1.3
—
—
—
0
0
67
657
1.03
0.04
4.0
3.4
—
—
—
0
0
30
311
0.96
0.04
1.2
1.3
15.9
27.8
iu/ml
—
8
97
33
321
1.03
0.02
1.4
1.5
—
—
—
0
0
39
399
0.97
0.02
1.4
1.3
3.1
1.2
u/ml
—
5
103
14
134
1.05
0.00
2.1
1.9
—
—
—
0
0
30
299
1.00
0.00
1.1
1.3
1.2
11.9
u/ml
2.26
16
116
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
8
89
0.90
0.00
3.5
6.8
24.8
25.0
mmol/l
—
8
84
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
0.00
2.0
1.4
—
—
—
0
0
5
57
0.87
0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
32.0
—
0
7
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
6.7
—
0
7
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
96
0.93
0.00
1.1
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_TRUNK_EXALLC – Benign neoplasm: Connective and other soft tissue of trunk, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).